Annual CFO:
-$40.66M-$17.27M(-73.88%)Summary
- As of today, AKBA annual cash from operations is -$40.66 million, with the most recent change of -$17.27 million (-73.88%) on December 31, 2024.
- During the last 3 years, AKBA annual cash from operations has risen by +$212.31 million (+83.93%).
- AKBA annual cash from operations is now -170.22% below its all-time high of $57.91 million, reached on December 31, 2016.
Performance
AKBA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$22.34M+$35.93M(+264.46%)Summary
- As of today, AKBA quarterly cash from operations is $22.34 million, with the most recent change of +$35.93 million (+264.46%) on June 1, 2025.
- Over the past year, AKBA quarterly cash from operations has increased by +$32.41 million (+321.98%).
- AKBA quarterly cash from operations is now -76.64% below its all-time high of $95.67 million, reached on December 31, 2016.
Performance
AKBA Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$2.40M+$32.41M(+93.10%)Summary
- As of today, AKBA TTM cash from operations is -$2.40 million, with the most recent change of +$32.41 million (+93.10%) on June 1, 2025.
- Over the past year, AKBA TTM cash from operations has increased by +$36.57 million (+93.83%).
- AKBA TTM cash from operations is now -102.92% below its all-time high of $82.26 million, reached on June 30, 2017.
Performance
AKBA TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AKBA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -73.9% | +322.0% | +93.8% |
| 3Y3 Years | +83.9% | +172.9% | +98.6% |
| 5Y5 Years | +84.2% | -40.0% | +98.6% |
AKBA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -73.9% | +83.9% | -33.9% | +140.9% | at high | +97.0% |
| 5Y | 5-Year | -73.9% | +84.2% | -33.9% | +131.6% | at high | +99.0% |
| All-Time | All-Time | -170.2% | +84.2% | -76.6% | +116.2% | -102.9% | +99.1% |
AKBA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $22.34M(+264.5%) | -$2.40M(+93.1%) |
| Mar 2025 | - | -$13.59M(-204.2%) | -$34.81M(+14.4%) |
| Dec 2024 | -$40.66M(-73.9%) | -$4.47M(+33.3%) | -$40.66M(-5.6%) |
| Sep 2024 | - | -$6.70M(+33.5%) | -$38.50M(+1.2%) |
| Jun 2024 | - | -$10.07M(+48.2%) | -$38.97M(-54.2%) |
| Mar 2024 | - | -$19.43M(-741.9%) | -$25.28M(-8.1%) |
| Dec 2023 | -$23.38M(+68.0%) | -$2.31M(+67.8%) | -$23.38M(+69.1%) |
| Sep 2023 | - | -$7.17M(-297.5%) | -$75.75M(-117.8%) |
| Jun 2023 | - | $3.63M(+120.7%) | -$34.78M(+49.6%) |
| Mar 2023 | - | -$17.54M(+67.9%) | -$69.07M(+5.6%) |
| Dec 2022 | -$73.15M(+71.1%) | -$54.68M(-261.7%) | -$73.15M(+10.0%) |
| Sep 2022 | - | $33.80M(+210.3%) | -$81.28M(+52.6%) |
| Jun 2022 | - | -$30.66M(-41.8%) | -$171.36M(+15.9%) |
| Mar 2022 | - | -$21.62M(+65.6%) | -$203.84M(+19.4%) |
| Dec 2021 | -$252.97M(-129.2%) | -$62.81M(-11.6%) | -$252.97M(-14.5%) |
| Sep 2021 | - | -$56.27M(+10.9%) | -$220.94M(-15.1%) |
| Jun 2021 | - | -$63.14M(+10.7%) | -$191.91M(-109.6%) |
| Mar 2021 | - | -$70.75M(-129.8%) | -$91.55M(+17.1%) |
| Dec 2020 | -$110.39M(+57.1%) | -$30.78M(-13.0%) | -$110.39M(+35.7%) |
| Sep 2020 | - | -$27.24M(-173.2%) | -$171.74M(-28.6%) |
| Jun 2020 | - | $37.22M(+141.5%) | -$133.51M(+36.1%) |
| Mar 2020 | - | -$89.59M(+2.8%) | -$209.10M(+18.8%) |
| Dec 2019 | -$257.44M(-164.1%) | -$92.14M(-938.4%) | -$257.44M(-7.7%) |
| Sep 2019 | - | $10.99M(+128.6%) | -$239.00M(+8.9%) |
| Jun 2019 | - | -$38.37M(+72.2%) | -$262.45M(-22.0%) |
| Mar 2019 | - | -$137.93M(-87.2%) | -$215.09M(-120.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$97.49M(-73.6%) | -$73.70M(-491.4%) | -$97.49M(-142.7%) |
| Sep 2018 | - | -$12.46M(-238.5%) | -$40.17M(+51.2%) |
| Jun 2018 | - | $9.00M(+144.2%) | -$82.33M(-23.0%) |
| Mar 2018 | - | -$20.33M(-24.1%) | -$66.96M(-19.2%) |
| Dec 2017 | -$56.16M(-197.0%) | -$16.38M(+70.0%) | -$56.16M(-200.5%) |
| Sep 2017 | - | -$54.62M(-324.2%) | $55.89M(-32.1%) |
| Jun 2017 | - | $24.36M(+355.7%) | $82.26M(+165.8%) |
| Mar 2017 | - | -$9.53M(-110.0%) | $30.94M(-46.6%) |
| Dec 2016 | $57.91M(+210.5%) | $95.67M(+438.7%) | $57.91M(+195.4%) |
| Sep 2016 | - | -$28.24M(-4.8%) | -$60.68M(-46.3%) |
| Jun 2016 | - | -$26.95M(-254.6%) | -$41.46M(-55.7%) |
| Mar 2016 | - | $17.43M(+176.1%) | -$26.63M(+49.2%) |
| Dec 2015 | -$52.41M(-90.7%) | -$22.91M(-153.7%) | -$52.41M(-35.4%) |
| Sep 2015 | - | -$9.03M(+25.5%) | -$38.70M(-9.7%) |
| Jun 2015 | - | -$12.12M(-45.2%) | -$35.27M(-18.3%) |
| Mar 2015 | - | -$8.35M(+9.3%) | -$29.82M(-8.5%) |
| Dec 2014 | -$27.48M(-142.5%) | -$9.20M(-64.3%) | -$27.48M(-18.5%) |
| Sep 2014 | - | -$5.60M(+16.0%) | -$23.19M(-13.0%) |
| Jun 2014 | - | -$6.67M(-11.0%) | -$20.52M(-29.8%) |
| Mar 2014 | - | -$6.01M(-22.4%) | -$15.81M(-39.5%) |
| Dec 2013 | -$11.33M(-57.1%) | -$4.91M(-67.1%) | -$11.33M(-76.4%) |
| Sep 2013 | - | -$2.94M(-50.1%) | -$6.42M(-84.3%) |
| Jun 2013 | - | -$1.96M(-27.9%) | -$3.49M(-127.9%) |
| Mar 2013 | - | -$1.53M | -$1.53M |
| Dec 2012 | -$7.21M(+48.9%) | - | - |
| Dec 2011 | -$14.12M | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Akebia Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Akebia Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of AKBA is -$40.66M
What is the all-time high annual cash from operations for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual cash from operations is $57.91M
What is Akebia Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, AKBA annual cash from operations has changed by -$17.27M (-73.88%)
What is Akebia Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of AKBA is $22.34M
What is the all-time high quarterly cash from operations for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly cash from operations is $95.67M
What is Akebia Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, AKBA quarterly cash from operations has changed by +$32.41M (+321.98%)
What is Akebia Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of AKBA is -$2.40M
What is the all-time high TTM cash from operations for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM cash from operations is $82.26M
What is Akebia Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, AKBA TTM cash from operations has changed by +$36.57M (+93.83%)